End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.26 CNY | -0.76% | -0.13% | -16.08% |
Apr. 26 | Winner Medical's Q1 Profit Drops 52% as Operating Income Slides 19% | MT |
Apr. 26 | Winner Medical's 2023 Profit Shrinks 65%, Operating Income Falls 28% | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.08% | 2.55B | C+ | ||
+9.48% | 27.45B | B+ | ||
-28.65% | 3.11B | B- | ||
+19.05% | 2.48B | - | A- | |
+11.11% | 2.08B | B | ||
-4.24% | 2.03B | - | ||
+5.56% | 1.55B | B | ||
+1.69% | 1.29B | - | ||
+29.73% | 1.23B | C | ||
+8.01% | 1.16B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 300888 Stock
- Ratings Winner Medical Co., Ltd.